From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 996.00
+1.00 (0.10%)
At close: May 21, 2026
From Bio Co.,Ltd Revenue
In the year 2025, From Bio Co.,Ltd had annual revenue of 72.16B KRW with 7.41% growth. From Bio Co.,Ltd had revenue of 19.51B in the quarter ending December 31, 2025, with 12.03% growth.
Revenue
72.16B
Revenue Growth
+7.41%
P/S Ratio
0.39
Revenue / Employee
515.44M
Employees
n/a
Market Cap
28.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.16B | 4.98B | 7.41% |
| Dec 31, 2024 | 67.18B | 457.90M | 0.69% |
| Dec 31, 2023 | 66.72B | -32.61B | -32.83% |
| Dec 31, 2022 | 99.33B | -35.77B | -26.48% |
| Dec 31, 2021 | 135.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DAP Corporation | 543.20B |
| SAMJIN | 148.32B |
| Jeong Moon Information. | 89.80B |
| Vitzrosys. | 44.81B |
| Wing's Foot | 41.96B |
| NP Inc. | 26.74B |
| PlumbFast | 25.23B |
| Innosimulation | 18.95B |